Safety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer
Related Posts
Lau CE, DiTullio DJ, Wilhalme H, Bowles L, Moore TB, De Oliveira SN. Prevalence of Viral Infections and Serious Complications in Pediatric Hematopoietic Stem Cell[...]
Williams S, Shauly O, Menon A, Jolkovsky E, Gould DJ, Losken A. Efficacy of Mesh Use in Breast Surgery: A Comprehensive Review of Complications and[...]
Harimohan H, Bilagi R, Huynh Q. Giant Cell Arteritis and the Use of Ultrasound in Its Diagnosis. Cureus. 2025 Jan 11;17(1):e77283. doi: 10.7759/cureus.77283. PMID: 39931599;[...]